highest dose of retatrutide in adults with obesity over 104 weeks in the group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Watch This Video BEFORE Taking

About 45% of the 2,339 patients in the trial lost 30% or more

For most people, their lost weight comes back

Top Places MiraviGLP Readers Compare for Retatrutide Online Readers who come from ranking sites tend to compare these five research suppliers

The lower availability of MOR in obese individuals may contribute to overeating as a way to compensate for reduced pleasure responses in this system

Beyond that, a head-to-head comparison from the SURMOUNT-5 trial illustrates the difference clearly: Participants taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide

That's still a workable approach if you're staying for several days